Early changes preceding beta cell autoimmunity and type 1 diabetes

Description of the granted funding

Type 1 diabetes (T1D) is heterogeneous autoimmune disease that has high prevalence in developed countries. It has severe long-term complications and constitutes a significant challenge to the health care system. Our goal is to improve understanding of disease process by studying changes in immune cells during early stages of disease development. Further, we aim at discovering and validating these changes that could potentially be used to predict, diagnose and monitor T1D. We will combine expertise and methods from different disciplines including clinical research, cutting-edge experimental methods and computational systems biology. Our results are expected to increase understanding of the pathogenesis of human T1D and immune response early in the disease process. We expect to discover and validate candidate biomarkers that identify individuals with risk to develop T1D, which in turn will provide new opportunities for early prevention and treatment of the disease.
Show more

Starting year

2021

End year

2022

Granted funding

Toni Grönroos Orcid -palvelun logo
78 737 €

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Other information

Funding decision number

340231

Fields of science

Genetics, developmental biology, physiology

Research fields

Perinnöllisyystiede

Identified topics

diabetes, medicine, metabolic diseases